Chronic periodontitis and its possible association with oral squamous cell carcinoma - a retrospective case control study

被引:48
|
作者
Moergel, Maximilian [1 ]
Kaemmerer, Peer [1 ,2 ]
Kasaj, Adrian [3 ]
Armouti, Evangelia [1 ]
Alshihri, Abdulmonem [4 ]
Weyer, Veronika [5 ]
Al-Nawas, Bilal [1 ]
机构
[1] Univ Med Ctr Mainz, Dept Oral & Maxillofacial Surg, D-55131 Mainz, Germany
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Univ Med Ctr Mainz, Dept Operat Dent, D-55131 Mainz, Germany
[4] Harvard Univ, Sch Dent Med, Dept Restorat & Biomat Sci, Boston, MA 02115 USA
[5] Univ Med Ctr Mainz, IMBEI, D-55131 Mainz, Germany
来源
HEAD & FACE MEDICINE | 2013年 / 9卷
关键词
Chronic periodontitis; Bone loss; Oral squamous cell carcinoma; Retrospective; Primary prevention; COULD CAUSE CANCER; HUMAN-PAPILLOMAVIRUS; COLORECTAL-CANCER; CHRONIC INFLAMMATION; RISK; EPIDEMIOLOGY; ASPIRIN; EXPRESSION; INFECTION; LESIONS;
D O I
10.1186/1746-160X-9-39
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Introduction: Different inflammatory processes may trigger the development of malignancies. Therefore, the aim of the present study was to evaluate a potential association between radiological determined chronic periodontitis (CPA) and oral squamous cell carcinoma (OSCC). Methods: In a retrospective study, OSCC-patients and a control group without malignant tumors were radiographically examined for bone loss. Via telephone survey and questionnaire, general clinical data on the individual oral hygiene and concomitant diseases together with tobacco and alcohol use were assessed and data were compared between the groups. Results: 178 OSCC-patients and 123 controls were included. In univariate analysis, a statistically relevant higher mean bone loss was seen in the OSCC group (4.3 mm (SD: 1.8; 95% confidence interval (CI): 4-4.6) vs. 2.9 mm (SD: 0.7; 95% CI: 2.8-3); p < 0.001)). This was confirmed in a multivariate regression model (OR: 2.4, 95% CI: 1.5-3.8; p < 0.001). A history of periodontal treatment was associated with significantly reduced OSCC risk (p < 0.001; OR: 0.2, CI: 0.1-0.5). Conclusions: CPA is a common disease and the monitoring as well as the treatment of such a chronic oral inflammation may be beneficial in reducing one potential cause of OSCC. Therefore, further clinical studies on oral neoplasms should consider clinical periodontal parameters as well.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Cytokines levels in saliva in periodontitis, oral potentially malignant disorders and squamous cell carcinoma
    Adamov, Angel
    Bolyarova-Konova, Teodora
    Stanimirov, Pavel
    Aleksiev, Evgeniy
    Kandilarova, Snezhina Mihailova
    Miteva, Marina
    Yankova, Petya
    Ishkitiev, Nikolay
    Mihaylova, Zornitsa
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2024, 38 (01)
  • [42] The localization and risk factors of squamous cell carcinoma in the oral cavity: A retrospective study of 1501 cases
    Sundermann, Britta V.
    Uhlmann, Lorenz
    Hoffmann, Juergen
    Freier, Kolja
    Thiele, Oliver C.
    JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2018, 46 (02) : 177 - 182
  • [43] Risk factors associated with the mortality rate of oral squamous cell carcinoma patients A 10-year retrospective study
    Ahmad, Paras
    Nawaz, Rubbia
    Qurban, Maria
    Shaikh, Gul Muhammad
    Mohamed, Roshan Noor
    Nagarajappa, Anil Kumar
    Asif, Jawaad Ahmed
    Alam, Mohammad Khursheed
    MEDICINE, 2021, 100 (36)
  • [44] The effects of periodontitis associated microbiota on the development of oral squamous cell carcinoma
    Hu, Xiaoyu
    Shen, Xin
    Tian, Jiangxue
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 576 : 80 - 85
  • [45] Epstein- Barr viral load in exfoliated cells of oral squamous cell carcinoma and oral potentially malignant disorders - A cross-sectional study
    Mahalingam, Kailash Kumar Gopalakrishnan
    Sankar, Leena Sankari
    Masthan, K. M. K.
    Mahalakshmi, Krishnan
    Kumar, Venkatesan Naveen
    JOURNAL OF CLINICAL VIROLOGY PLUS, 2021, 1 (04):
  • [46] Oral squamous cell carcinoma in an Iranian population: a retrospective study of 249 cases
    Ansari, M. H.
    ORAL ONCOLOGY, 2007, : 135 - 135
  • [47] Multicenter retrospective study of nivolumab for recurrent/metastatic oral squamous cell carcinoma
    Yamakawa, Nobuhiro
    Umeda, Masahiro
    Yoshii, Yumi
    Mitsudo, Kenji
    Noguchi, Makoto
    Kusukawa, Jingo
    Katakura, Akira
    Nakayama, Hideki
    Sasaki, Masashi
    Noguchi, Tadahide
    Ueda, Michihiro
    Bukawa, Hiroki
    Yagihara, Kazuhiro
    Horie, Akihisa
    Miyazaki, Akihiro
    Chikazu, Daichi
    Tomihara, Kei
    Mishima, Katsuaki
    Otsuru, Mitsunobu
    Asoda, Seiji
    Fujiwara, Shigeyoshi
    Ohyama, Yoshio
    Kurita, Hiroshi
    Kawamata, Hitoshi
    Fukuda, Masayuki
    Shintani, Yukari
    Kobayashi, Takanori
    Kanno, Takahiro
    Oh-Iwa, Ichiro
    Kawano, Kenji
    Yamashita, Yoshio
    Kobayashi, Wataru
    Ohiro, Yoichi
    Uzawa, Katsuhiro
    Ota, Yoshihide
    Kirita, Tadaaki
    ORAL DISEASES, 2024, 30 (02) : 247 - 258
  • [48] Clinicopathological characteristics of oral squamous cell carcinoma in Northern Norway: a retrospective study
    Oddveig G Rikardsen
    Inger-Heidi Bjerkli
    Lars Uhlin-Hansen
    Elin Hadler-Olsen
    Sonja E Steigen
    BMC Oral Health, 14
  • [49] Expression of sexual hormone receptors in leukoplakia and oral squamous cell carcinoma: a case control study
    Panzarella, V.
    Colella, G.
    Campisi, G.
    Ferrara, D.
    Lanza, A.
    Izzo, G.
    Minucci, S.
    ORAL ONCOLOGY, 2007, : 199 - 199
  • [50] An inverse association of Helicobacter pylori infection with oral squamous cell carcinoma
    Meng, Xue
    Wang, Qiuxu
    He, Caiyun
    Chen, Moye
    Liu, Jingwei
    Liu, Weixian
    Yuan, Yuan
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2016, 45 (01) : 17 - 22